Valeant Buys INova From PE Firms For $688M
Canadian drugmaker Valeant Pharmaceuticals Inc. is enhancing its global presence with the AU$700 million (US$688 million) acquisition of Australia's iNova Pharmaceuticals Pty Ltd. from private equity investors, Valeant announced Sunday....To view the full article, register now.
Already a subscriber? Click here to view full article